Danaher Corporation (NYSE:DHR) stock has experienced a notable downturn, reaching a 52-week low of $225.36. With a market ...

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...

Danaher Corporation DHR reported weaker-than-expected fourth-quarter earnings on Wednesday. The company reported fourth-quarter adjusted earnings per share of $2.14 missing the street view of $2.16.

1 Day DHR 1.95% DJIA 0.65% S&P 500 -1.46% Health Care/Life Sciences -0.52% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Danaher Corporation (NYSE:DHR) traded ~5% lower in the premarket on Wednesday after the company, with its Q4 2024 results, projected its Q1 2025 non-GAAP core revenue to drop low-single digits from ...

Baird analyst Catherine Schulte lowered the firm’s price target on Danaher (DHR) to $258 from $268 and keeps an Outperform rating on the ...

Quarterly orders topped estimates, as companies scrambled to get their hands on machinery to make increasingly sophisticated semiconductors. U.S.-listed ASML sto ...

In a report released today, Brandon Couillard from Wells Fargo maintained a Hold rating on Danaher (DHR – Research Report), with a price target ...

U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...

The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $2.17 per share. The industrial and medical device maker posted revenue of $6.54 billion in the period, ...

This positive outcome has rippled through the industry, with Danaher and Thermo Fisher anticipating their own earnings reports later this week. Analysts have weighed in on Sartorius's results, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...